天津九安医疗电子股份有限公司 关于回购公司股份比例达到1%的进展公告

Core Viewpoint - The company has approved a share repurchase plan with a total funding amount between 300 million RMB and 600 million RMB, with a maximum repurchase price of 53.5 RMB per share [1] Group 1: Share Repurchase Plan - The company convened the 27th meeting of the 6th Board of Directors on October 13, 2025, to review and approve the share repurchase plan [1] - The total amount spent on share repurchase as of October 21, 2025, is 204,352,396.47 RMB, with a total of 5,076,901 shares repurchased, accounting for 1.09% of the company's total share capital [1] - The highest transaction price during the repurchase was 40.883 RMB per share, while the lowest was 39.83 RMB per share [1] Group 2: Compliance with Regulations - The company has adhered to the relevant regulations regarding the timing, quantity, and price of the share repurchase, as outlined in the Shenzhen Stock Exchange's self-regulatory guidelines [2] - The company did not repurchase shares during periods that could significantly impact the stock price or during other restricted periods as defined by regulatory authorities [2][3] - The company will continue to implement the repurchase plan based on market conditions and will fulfill its information disclosure obligations as required [3]